Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan Ruchika Sharma23 Dec 2023 12:30 PM ISTAdalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
Biocon arm completes integration of Viatris biosimilars business in 120 countries Ruchika Sharma19 Dec 2023 11:43 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced the successful completion of the transition of the acquired...
Biocon arm concludes integration of Viatris biosimilar business in 31 European countries Ruchika Sharma30 Nov 2023 5:33 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the integration of the Viatris' biosimilars business in 31...
Biocon arm gets UK MHRA marketing authorisation for ophthalmic drug Yesafili Ruchika Sharma14 Nov 2023 11:29 AM ISTIt is highly similar to the reference product Eylea (aflibercept).
Biocon Biologics to divest dermatology, nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore Ruchika Sharma9 Nov 2023 11:45 AM ISTThe divestiture is expected to close by the end of Nov 2023, subject to customary closing conditions.
Ex Cipla Global CFO Kedar Upadhye appointed as new CFO of Biocon Biologics Ruchika Sharma20 Oct 2023 2:30 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the Board of Directors of Biocon Biologics have appointed Kedar Upadhye...
Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility Ruchika Sharma18 Oct 2023 12:30 PM ISTBengaluru: Biocon Sdn Bhd., a step-down subsidiary of Biocon Biologics Limited has received a communication from the U.S. Food and Drug...
Biocon Biologics gets European Commission nod for critical eye treatment medicine Yesafili Ruchika Sharma21 Sept 2023 1:30 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that the European Commission (EC) has granted marketing authorization in...
Prove efficacy of Itolizumab for subcutaneous route: CDSCO panel Tells Biocon Biologics Dr. Divya Colin13 Sept 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Biocon...
Executive Chairperson of Biocon Kiran Mazumdar Shaw appointed as member of court of Regents at Royal College of Surgeons of Edinburgh Roshni Dhar8 Sept 2023 3:45 PM ISTKiran Mazumdar-Shaw, Executive Chairperson of Biocon Ltd. and Biocon Biologics Ltd., has been appointed as Regent of the Royal College of Surgeons of...
Biocon Chief Kiran Mazumdar-Shaw appointed as member of Court of Regents at Royal College of Surgeons of Edinburgh Ruchika Sharma7 Sept 2023 6:15 PM ISTBengaluru: Kiran Mazumdar-Shaw, Executive Chairperson of Biocon Ltd. and Biocon Biologics Ltd., has been appointed as Regent of the Royal...
Biocon Biologics completes integration of acquired biosimilars business from Viatris in North America Ruchika Sharma7 Sept 2023 12:16 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the Company has completed the integration of the acquired ...
